Plantar Fasciitis (pronounced plantar fashee-i-tis) commonly referred to as "heel spurs" or "heel pain syndrome" affects approximately 40 million Americans yearly. It affects men and women of all ages, and activity levels. The most common symptom is morning pain, sharp shooting pain upon arising from bed or a resting position.
Treated early, eighty-five to ninety percent of those diagnosed with plantar fasciitis will heal with conservative treatment. Conservative measures include rest, anti-inflammatory medication, steroidal injections, cushioning, and conditioning exercise.
The OssaTron® Orthotripsy provides an alternate treatment for those who fail conservative treatment. Prior to FDA approval of the OssaTron, the only alternative for those who did not respond to conservative treatment was invasive surgery with increased risk of infection and prolonged recovery time.
The OssaTron has been proven highly effective for those with chronic proximal plantar fasciitis. Studies conducted in the United States show an 81% success rate after a single treatment. Long term results show that virtually all of those patients who were success at 12 week follow up visits retained their success criteria at 12 months, and those who voluntarily continued follow up visits did not have a recurrence of symptoms for as long as 5 years.